Anti-HIV-1 neutralizing antibodies

Details Anti-HIV-1 neutralizing antibodies Anti-HIV-1 neutralizing antibodies

1993-12-27

1996-06-25

Feisee, Lila

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Binds virus or component thereof

5303894, A61K 3942, C07K 1600

Patent

active

055297765

ABSTRACT:
The disclosure relates to antibodies reactive with HIV-1 antigens and the use of such antibodies in vaccine preparations, immunotherapeutic preparations and assays for HIV-1.

REFERENCES:
patent: 4132769 (1979-01-01), Osther
patent: 4520113 (1985-05-01), Gallo et al.
patent: 4725669 (1988-02-01), Essex et al.
patent: 4863730 (1989-09-01), Karpas
Prince et al. J. Cell. Biochem. Suppl. p. 44 1988. 12 Part B. J. of Cellular Biology.
Jackson et al. Lancet 2 647-651 1988.
Jon Cohen Science vol. 265:1028 1994.
Fahey et al. Clin Expt. Immunol. 88:1-5 1988.
Thouvenot et al., Appl. Environ. Microb. 45:16-23 (1983).
Essex, M. et al., Ann. Int. Med. 103:700-703 (1985).
di Merzo Veronese, F. et al., Science 231:1289-1291 (1986).
Robey et al. PNAS vol. 83:7023-7027 (1986).
Laskey et al. Science 233:209 (1986).
The Lancet, p. 566 (Mar. 7, 1987).
The Lancet p. 632 (Mar. 14, 1987).
Pan et al. J. Infec. Dis. 155:626-632 (1987).
Buchegger, F. et al., INCI 79:337-343 (1987).

Affiliated with

Also associated with

Rating

Anti-HIV-1 neutralizing antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-HIV-1 neutralizing antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-HIV-1 neutralizing antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2187163